Role of NOX2 in the regulation of inflammatory and apoptotic pathways in congolese patients with type 2 diabetes in Brazzaville.

In our study, patients on DPP-4 inhibitors alone presented numerically lower adjusted NOX2 levels (18.9 ± 1.2 ng/mL) compared to those on metformin alone (19.8 ± 0.9 ng/mL) or sulfonylureas (20.6 ± 1.1 ng/mL), although these differences did not reach statistical significance in post-hoc comparisons.

also in 111,027 other papers